Name |
Chemical name |
CAS NO. |
Dapoxetine intermediate series |
DB0 |
3-Chloropropiophenone |
936-59-4 |
DB1 |
(S)-3-Amino-3-phenylpropan-1-ol |
82769-76-4 |
DB2 |
(S)-3-Amino-3-phenylpropanoic acid |
40856-44-8 |
DB3 |
(R)-Diphenylprolinol |
22348-32-9 |
DB4 |
(S)-Diphenylprolinol |
112068-01-6 |
DB5 |
(S)-(-)-3-chloro-1-phenyl 1-propanol |
100306-34-1 |
DB6 |
(1R)-3-Chloro-1-phenyl-propan-1-ol |
100306-33-0 |
DB7 |
3-CHLORO-1-PHENYL-1-PROPANOL |
18776-12-0 |
DB8 |
Dapoxetine |
119356-77-3 |
D1 |
Dapoxetine hydrochloride |
129938-20-1 |
D2 |
Dapoxetine hydrochloride |
129938-20-1 |
Atorvastatin intermediate |
Ats-4 |
Ehyl-4-(-)chloro-3-hydroxybutyrate |
86728-85-0 |
Ats-5 |
(R)-4-cyano-3-hydroxybutyric acid ethyl ester |
141942-85-0 |
Ats-8 |
(4R,Cis)-1,1-dimethylethyl-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
125971-94-0 |
Ats-9 |
(4R,Cis)-1,1-dimethylethyl6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-Acetate |
125995-13-3 |
M-1 |
methyl isobutyl acetate |
42558-54-3 |
M-2 |
4-methyl-3-oxo-N-phenyl pentanamide |
124401-38-3 |
M-3 |
4-methyl-3-oxo-N-phenyl-2- (phenylmethylene) pentanamide |
125971-57-5 |
M-4 |
4-fluoro-a-[2-methyl-1-oxopropyl]-γ-oxo-N,β- diphenylbenzene butaneamide |
125971-96-2 |
M-K |
3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide |
54016-70-5 |
L-1 |
(4R-cis)-1,1-dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate |
125971-95-1 |
L-2 |
(4R-cis)-1,1-dimethylethyl-6-[2-[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dihydroxy-4-acetate |
134395-00-9 |
L-4 |
(3R, 5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)
Pyrrol-1-yl]-3, 5 -Dihydroheptanoic Acid, calcium salt (2:1) Trihydrate (crystal) |
134523-03-8 |
L-5 |
[(3R, 5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl) Pyrrol-1-yl]-3, 5 -Dihydroheptanoic Acid, calcium salt (2:1) Trihydrate (Amorphous) |
134523-03-8 |
L-6 |
5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide |
125995-03-1 |
L-7 |
(3R ,5R )-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4
-(Pheynylcarbamoyl)Pyrrol-1-yl]-3 ,5 -Dihydro heptanoic Acid |
134523-00-5 |
L-8 |
(3R,5R)-7-[2-(4-Fluorophenyl)-5-Isopropyl-3-Phenyl-4-(Pheynylcarbamoyl)Pyrrol-1-yl]-3 ,5
-Dihydroheptanoic Acid, Sodium salt |
131275-93-9 |
Fluvastatin intermediate series |
F-1 |
3-(4'-fluorophenyl)-1-(1'-methylethyl)-1H-indole |
93957-49-4 |
F-2 |
(E)-3-[3'-(4"-fluorophenyl)-1'-(1"-methylethyl)-1H-indole-2"yl] prop-2-enal |
93957-50-7 |
F-3 |
T-BUTYL(E)-7-[3'(4''-FLUOROPHENYL)-1'-METHYLETHYL-INDOL-2'-YL]-3-HYDROXY-5-OXO-6-HEPTENOATE |
93957-52-9 |
F-4 |
Tert-butyl(E)-3,5-Dihydroxy-7-[3-(4-Fluorophenyl)-1- Methylethyl-Indol-2'-yl] Hept-6-enoate |
93957-53-0 |
F-5 |
Sodium(+-) (E)-3,5-dihydroxy-7-[3'-(4"-fluorophenyl)-1'-methylethyl-indol-2'-yl] hept-6-enoate |
93957-55-2 |
Rosuvastatin intermediate series |
C-2 |
(4R-CIS)-6-[ (ACETYLOXY)METHYL ]-2,2-DIMETHYL-1,
3-DIOXANE-4-ACETIC ACID,1,1-DIMETHYLETHYL ESTER |
|
C-3 |
(4R-cis)-6-Hydroxymethyl-2,2-dimethyl-1,
3-dioxane-4-acetic acid,1,1-dimethylethyl ester |
154026-94-5 |
C-4 |
(4R-cis)-6-formaldehydel-2,2-dimethyl-1, 3-dioxane-4-acetic acid,1,1-dimethylethyl ester |
154026-95-6 |
C-5 |
(4R-cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-aceticacid,
1,1-dimethylethyl ester |
124655-09-0 |
C-6 |
(4R-cis)-6-formaldehydel-2,2-dimethyl-1, 3-dioxane-4-acetic acid,1,1-dimethylethyl ester |
124752-23-4 |
J-3 |
(3R)-3-[(tert-butyldimethylsilyl)oxy]glutaric anhydride |
91424-40-7 |
J-4 |
(3R)-3-[(tert-butyldimethylsily)oxy]pentanedioate-1-Methylmonoester |
109744-49-2 |
J-5 |
1,5-Ethoxycarbonylmethyl-(3r)-3-tert-butyl-dimethylsilyloxy pentanedioate |
158275-79-7 |
J-6 |
Methyl(3r)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanoate |
147118-35-2 |
H-1 |
7-[4-fluorophenyl]-6-isopropyl)-2-(N-Methyl-N-MethylSulfonyl amino)pyrimidine-5-yl]-(3R)-3-(terbutyldimethylsilyloxy)-5-oxo-6E-heptane acid,Methyl ester |
147118-38-5 |
H-2 |
Methyl(+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate |
147118-39-6 |
H-3 |
7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(N-methyl-N-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid methyl ester |
147118-40-9 |
Na salt |
(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl]-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-yl]-3,5-dihydroxy-6-heptane acid,Sodium |
147098-18-8 |
Z-5 |
METHYL 4-(4-FLUOROPHENYL)6-ISOPROPYL-2-(N-METHYL-N-METHYLSULFONYL)AMINO] PYRIMIDINE-5-CARBOXYLATE |
|
Z-6 |
METHYL 4-(4-FLUOROPHENYL)6-ISOPROPYL-2-(N-METHYL-N-METHYLSULFONYL)AMINO] PYRIMIDINE-5-CARBOXYLATE |
289042-11-1 |
Z-7 |
4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[ (N-METHYL-N-METHYLSULFONYL)AMINO ] PYRIMIDINE-5-YL-METHONOL |
147118-36-3 |
Z-8 |
Diphenyl[4-(4-fluorophenyl)-6-isopropyl-2-(N-Methyl-N-Methylsulfonylamino)Pyrimidine PRODUCT:Chemical name:Diphenyl[4-(4-fluorophenyl)-6-isopropyl-2-(N-Methyl-N-Methylsulfonylamino)Pyrimidine |
799842-07-2 |
Z-8.1 |
4-(4-fluorophenyl)-6-isopropyl-2-[(n-methyl-n-methylsulfonyl)amino] pyriminl-5-yl- phosphine oxide |
289042-10-0 |
Z-8.2 |
Triphenyl[4-(4-fluorophenyl)-6-isopropyl-2-[(2-n-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methyl]phosphine bromine |
885477-83-8 |
Z-9 |
4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylSulfonyl amino)pyrimidine-5-carboxaldehyde |
147118-37-4 |
R-1 |
Tert-butyl-(+)7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-METHYL- N-methylsulfonylamino)pyrimidine-5-yl]-(3R,5S)-dioxane-(E)-6-heptenate |
289042-12-2 |
R-2 |
T-BUTYL 7-[4-(4-FLUOROPHENYL)-6-ISO-PROPYL-2-(N-METHYL-N-METHYLSULFONYLAMINO)PYRIMIDIN-5-YL] -(3R,5S)-DIHYDROXY-(E)-6-HEPTENATE |
355806-00-7 |
R-3 |
(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[N-methyl(n-methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-Heptenoic amine |
|
R-4 |
(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-isopropyl]-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-yl]-3,5-dihydroxy-6-heptane acid,Sodium |
147098-18-8 |
Acid |
7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid; Rosuvastatin ; 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl-methylsulfonyl-amino)-pyrimidin-5-yl]-3,5-dihydroxy-hept-6-enoic acid |
287714-41-4 |
R |
(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[N-methyl(n-methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-Heptenoic calcium . |
147098-20-2 |
Pitavastatin intermediate series |
PA |
2-Amino-4'-fluorobenzophenone |
3800-06-4 |
PB |
Methyl 4-(4'-fluorophenyl)-2-(cyclopropyl)-3-quinolinecarboxylate |
121659-86-7 |
P-0 |
Ethyl-2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxylate |
148516-11-4 |
P-1 |
2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol |
121660-11-5 |
P-2 |
2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-carboxaldehyde |
121660-37-5 |
PB2 |
2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-MethylBr |
154057-56-4 |
PB3 |
2-cyclopropyl-4-(4-fluorophenyl)-quinolyl-2-phenyloxophorusmethyl |
146578-99-6 |
PB3-2 |
[2-Cyclopropyl-4-(4-fluorophenyl)-quinolin-3-ylmethyl]-triphenyl-phosphonium bromido |
154057-58-6 |
PB4 |
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-2,2-Dimethyl-1,3-dioxane-6-heptenoic acid,1,1-dimethylethyl ester |
147489-06-3 |
PB5 |
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptenoic acid,1,1-dimethylethyl ester |
586966-54-3 |
PB6 |
(4R,6S,E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl-ethenylvinyl]-4-hydroxyl-3,4,5,6-H-2H-pyran-2-etone |
141750-63-2 |
PB7 |
(3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]- 3,5-dihydrosy-6-heptane acid,(+)phenyl ethylamine |
147511-70-4 |
PC2 |
(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propopenenitrile |
256431-72-8 |
PC3 |
(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-2-propenal |
148901-68-2 |
PC4 |
Ethyl (E)-7-[2-cyclopropyl-4-(4-flurophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate |
148901-69-3 |
PC5 |
Ethyl (E)-3,5-dihydroxy-7-[2-cyclopropyl-4-(4-flurophenyl)-3-quinolinyl]-hept-6-enoate |
172336-32-2 |
|
monocalciumbis[(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolyl)-3,5-Dihydroxy-6-heptenoate](+)α- Phenethylamine Salt |
147526-32-7 |
K3 |
(4R-Cis)-6-Chlorin-2,2-Dimethyl-1,3-Dihydrosy-4-acetic acid,1,1-dimethyl ethyl ester |
154026-94-5 |
K4 |
(4R-Cis)-6- Chlorin-2,2-Dimethyl-1,3-Dioxane-4-acetic acid,1,1-dimethyl ethyl ester |
154026-95-6 |
K5 |
(4R-cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-aceticacid,
1,1-dimethylethyl ester |
124665-09-0 |
K6 |
(4R-cis)-6-formaldehydel-2,2-dimethyl-1, 3-dioxane-4-acetic acid,1,1-dimethylethyl ester |
124752-23-4 |
Dapagliflozin intermediate series |
DGLJ-1 |
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
461432-22-4 |
DGLJ-2 |
5-bromo-2-chloro-4'-ethoxydiphenylmethane |
461432-23-5 |
DGLJ-3 |
(5-Iodo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
1103738-26-6 |
DGLJ-4 |
1-chloro-2-[(4-ethoxyphenyl)methyl]-4-iodo-Benzene |
1103738-29-9 |
DGLJ-5 |
[(2S,3S,4S,5R,6S)-6-bromo-3,4,5-tris(2,2-dimethylpropanoyloxy)tetrahydropyran-2-yl]methyl 2,2-dimethylpropanoate |
81058-27-7 |
DGLJ-API |
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
461432-26-8 |
Empagliflozin intermediate series |
EGLJ-1 |
(S)-(5-broMo-2-chlorophenyl)(4-(tetrahydrofuran-3-yloxy)phenyl)Methanone |
915095-84-0 |
EGLJ-2 |
(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan |
915095-89-5 |
EGLJ-3 |
(2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone |
915095-87-3 |
EGLJ-4 |
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan |
915095-94-2 |
EGLJ-5 |
[(2S,3S,4S,5R,6S)-6-bromo-3,4,5-tris(2,2-dimethylpropanoyloxy)tetrahydropyran-2-yl]methyl 2,2-dimethylpropanoate |
81058-27-7 |
EGLJ-API |
Empagliflozin |
864070-44-0 |
Bio-enzyme (biological enzyme)
|
|
Immobilized D-amino acid oxidase |
|
|
Immobilized GL-7-ACA acylase |
|
Organic Essences and Flavors
|